BR-108
N/A
Report date: 2026/03/20 20:03:07
Base Information
Drug NameBR-108
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang BioRay Biopharmaceuticals Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesZhejiang BioRay Biopharmaceuticals Co Ltd
Inactive CompaniesBioRay Pharmaceutical Co LtdHisun Biopharmaceutical Co Ltd
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A